ATE415150T1 - Pharmazeutische zusammensetzung mit verzögerte freisetzung enthaltend einen cephalosporin- antibiotikum - Google Patents
Pharmazeutische zusammensetzung mit verzögerte freisetzung enthaltend einen cephalosporin- antibiotikumInfo
- Publication number
- ATE415150T1 ATE415150T1 AT03787944T AT03787944T ATE415150T1 AT E415150 T1 ATE415150 T1 AT E415150T1 AT 03787944 T AT03787944 T AT 03787944T AT 03787944 T AT03787944 T AT 03787944T AT E415150 T1 ATE415150 T1 AT E415150T1
- Authority
- AT
- Austria
- Prior art keywords
- sustained release
- cephalosporin antibiotic
- release pharmaceutical
- pharmaceutical composition
- composition containing
- Prior art date
Links
- 229930186147 Cephalosporin Natural products 0.000 title abstract 3
- 230000003115 biocidal effect Effects 0.000 title abstract 3
- 229940124587 cephalosporin Drugs 0.000 title abstract 3
- 150000001780 cephalosporins Chemical class 0.000 title abstract 3
- 238000013268 sustained release Methods 0.000 title abstract 3
- 239000012730 sustained-release form Substances 0.000 title abstract 3
- 239000008194 pharmaceutical composition Substances 0.000 title abstract 2
- 239000000203 mixture Substances 0.000 abstract 4
- 229920000642 polymer Polymers 0.000 abstract 4
- 229920000926 Galactomannan Polymers 0.000 abstract 2
- 230000007935 neutral effect Effects 0.000 abstract 2
- 239000000546 pharmaceutical excipient Substances 0.000 abstract 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
- A61K47/32—Macromolecular compounds obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. carbomers, poly(meth)acrylates, or polyvinyl pyrrolidone
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/54—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one sulfur as the ring hetero atoms, e.g. sulthiame
- A61K31/542—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one sulfur as the ring hetero atoms, e.g. sulthiame ortho- or peri-condensed with heterocyclic ring systems
- A61K31/545—Compounds containing 5-thia-1-azabicyclo [4.2.0] octane ring systems, i.e. compounds containing a ring system of the formula:, e.g. cephalosporins, cefaclor, or cephalexine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/54—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one sulfur as the ring hetero atoms, e.g. sulthiame
- A61K31/542—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one sulfur as the ring hetero atoms, e.g. sulthiame ortho- or peri-condensed with heterocyclic ring systems
- A61K31/545—Compounds containing 5-thia-1-azabicyclo [4.2.0] octane ring systems, i.e. compounds containing a ring system of the formula:, e.g. cephalosporins, cefaclor, or cephalexine
- A61K31/546—Compounds containing 5-thia-1-azabicyclo [4.2.0] octane ring systems, i.e. compounds containing a ring system of the formula:, e.g. cephalosporins, cefaclor, or cephalexine containing further heterocyclic rings, e.g. cephalothin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
- A61K47/36—Polysaccharides; Derivatives thereof, e.g. gums, starch, alginate, dextrin, hyaluronic acid, chitosan, inulin, agar or pectin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/2004—Excipients; Inactive ingredients
- A61K9/2022—Organic macromolecular compounds
- A61K9/2031—Organic macromolecular compounds obtained otherwise than by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyethylene glycol, polyethylene oxide, poloxamers
- A61K9/204—Polyesters, e.g. poly(lactide-co-glycolide)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/2004—Excipients; Inactive ingredients
- A61K9/2022—Organic macromolecular compounds
- A61K9/205—Polysaccharides, e.g. alginate, gums; Cyclodextrin
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Epidemiology (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Inorganic Chemistry (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicinal Preparation (AREA)
- Cephalosporin Compounds (AREA)
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| IN601CH2002 | 2002-08-16 | ||
| US10/222,930 US20040033262A1 (en) | 2002-08-19 | 2002-08-19 | Sustained release pharmaceutical composition of a cephalosporin antibiotic |
| PCT/IB2002/003320 WO2004016250A1 (en) | 2002-08-19 | 2002-08-19 | Sustained release pharmaceutical composition of a cephalosporin antibiotic |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| ATE415150T1 true ATE415150T1 (de) | 2008-12-15 |
Family
ID=31891821
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| AT03787944T ATE415150T1 (de) | 2002-08-16 | 2003-08-18 | Pharmazeutische zusammensetzung mit verzögerte freisetzung enthaltend einen cephalosporin- antibiotikum |
Country Status (4)
| Country | Link |
|---|---|
| EP (1) | EP1534246B1 (de) |
| AT (1) | ATE415150T1 (de) |
| DE (1) | DE60324944D1 (de) |
| WO (1) | WO2004016251A1 (de) |
Families Citing this family (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CA2612994A1 (en) * | 2005-06-08 | 2006-12-08 | Elan Pharma International Limited | Nanoparticulate and controlled release compositions comprising cefditoren |
| HRP20151321T1 (hr) | 2011-01-20 | 2016-01-29 | Bionevia Pharmaceuticals Inc. | Epalrestat ili njegov derivat u oblicima s prilagođenim otpuštanjem te postupci uporabe istih |
Family Cites Families (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US6080427A (en) * | 1997-04-17 | 2000-06-27 | Bristol-Myers Squibb Company | Cefadroxil monohydrate tablet formulation |
| AU2001227030A1 (en) * | 2000-11-22 | 2002-06-03 | Lupin Laboratories Limited | Pharmaceutical composition for controlled release of an active ingredient |
| ATE303149T1 (de) * | 2001-02-27 | 2005-09-15 | Ranbaxy Lab Ltd | Orale pharmazeutische zusammensetzung aus cefpodoxim-proxetil |
-
2003
- 2003-08-18 WO PCT/IB2003/003340 patent/WO2004016251A1/en not_active Ceased
- 2003-08-18 EP EP03787944A patent/EP1534246B1/de not_active Expired - Lifetime
- 2003-08-18 DE DE60324944T patent/DE60324944D1/de not_active Expired - Fee Related
- 2003-08-18 AT AT03787944T patent/ATE415150T1/de not_active IP Right Cessation
Also Published As
| Publication number | Publication date |
|---|---|
| EP1534246B1 (de) | 2008-11-26 |
| WO2004016251A1 (en) | 2004-02-26 |
| DE60324944D1 (de) | 2009-01-08 |
| EP1534246A1 (de) | 2005-06-01 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| EA200000584A3 (ru) | Твердые фармацевтические композиции с контролируемым высвобождением, получаемые тепловым формованием | |
| JP2005524658A5 (de) | ||
| IT1282352B1 (it) | Composizione farmaceutica, in particolare essiccata mediante congelamento, per somministrazione orale di ondansetron e metodo per | |
| BG66093B1 (bg) | Състави с контролирано освобождаване, съдържащи нимесулид | |
| TW200635897A (en) | Piperidine derivatives and their use as anti-inflammatory agents | |
| MX2009013832A (es) | Derivados de purina y su uso como moduladores del receptor 7 similar a un puente. | |
| WO2007048219A3 (en) | Sustained drug release composition | |
| MX2008000099A (es) | Composiciones farmaceuticas de liberacion modificada novedosas, y procedimiento de preparacion de dichas composiciones. | |
| AR037931A1 (es) | Metodo para granulacion humeda de azitromicina | |
| NO20043367L (no) | Oralt farmasoytisk preparat | |
| ATE386725T1 (de) | Heterocyclylverbindungen | |
| ATE303149T1 (de) | Orale pharmazeutische zusammensetzung aus cefpodoxim-proxetil | |
| MXPA05007609A (es) | Antagonista de un receptor sensible al calcio. | |
| ATE519486T1 (de) | Pharmazeutische zusammensetzung mit einem monoamin-neurotransmitter-wiederaufnahmehemmer und einem acetylcholinesterase-hemmer | |
| TW200610540A (en) | Pharmaceutical compositions | |
| WO2008039406A3 (en) | Rapidly disintegrating lyophilized oral formulations of a thrombin receptor antagonist | |
| DE602004009552D1 (de) | Orales abgabesystem mit einem antibakteriellen und einem entzündungshemmenden mittel | |
| NO20032737L (no) | Fast termoformbar farmasöytisk sammensetning for den kontrollerte frigivelse av ivabradin | |
| SE0302570D0 (sv) | Benzimidazole derivatives, compositions containing them, preparation thereof and uses thereof | |
| AU2003267602A1 (en) | Polymer compositions for administration to animals | |
| UA89684C2 (ru) | Двухслойная фармацевтическая дозированная форма с модифицированным высвобождением нимесулида | |
| SE0302572D0 (sv) | Benzimidazole derivatives, compositions containing them, preparation thereof and uses thereof | |
| DE60324944D1 (de) | Pharmazeutische zusammensetzung mit verzögerte freisetzung enthaltend einen cephalosporin-antibiotikum | |
| ATE344026T1 (de) | Pharmazeutische formulierung mit einem nichtpeptidischen renin-hemmer und surfactant | |
| WO2007017331A3 (en) | Immediate release therapeutic systems for improved oral absorption of 7- [ (e) -tert-butyloxyiminomethyl] camptothecin |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| RER | Ceased as to paragraph 5 lit. 3 law introducing patent treaties |